Sorafenib dimethyl sulphoxide solvate

Details for Australian Patent Application No. 2011210326 (hide)

Owner Ranbaxy Laboratories Limited

Inventors Jaryal, Jagdev Singh; Sathyanarayana, Swargam; Thaper, Rajesh Kumar; Prasad, Mohan; Zade, Sachin Deorao; Singh, Ajay Shankar

Agent Callinan

Pub. Number AU-A-2011210326

PCT Pub. Number WO2011/092663

Priority 204/DEL/2010 29.01.10 IN

Filing date 28 January 2011

Wipo publication date 4 August 2011

International Classifications

C07D 213/81 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4412 - having oxo groups directly attached to the heterocyclic ring

Event Publications

16 August 2012 PCT application entered the National Phase

  PCT publication WO2011/092663 Priority application(s): WO2011/092663

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011210327-Crystalline forms of L-malic acid salt of sunitinib

2011210316-Polymer gel formulation